Alpha Lipoic Acid injectable vials recalled for sterility assurance failure
TMC Acquisition LLC is recalling Alpha Lipoic Acid 25mg/mL vials due to lack of assurance of sterility in manufacturing. The product was distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II FDA drug recall for a sterile injectable with a manufacturing sterility assurance defect. No illnesses or injuries have been reported in the source text. Per the rubric, this qualifies as a risk-of-harm product where injury has not yet been reported, placing it at Score 3 (High).
Plain-English summary
Alpha Lipoic Acid 25mg/mL injectable vials (30mL per vial) manufactured by TMC Acquisition LLC dba Tailor Made Compounding are being recalled nationwide in the USA and Puerto Rico.
The product is being recalled due to lack of assurance of sterility in the manufacturing process. Affected batches include #12082102A2 (expiration 3/8/2022) and #02212201A1 (expiration 5/22/2022). This is a Class II recall issued by the FDA.
Consumers and healthcare providers in possession of the recalled product should cease use immediately and contact their healthcare provider or the manufacturer for guidance on proper handling and replacement.
The recalled product
- Product
- Alpha Lipoic Acid 25mg/mL, 30mL-vial, Refrigerate, Tailor Made Compounding
- Manufacturer
- TMC Acquisition LLC dba Tailor Made Compounding
- Category
- Drug — Injectable / Compounded
- Hazard
- sterility-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Batch #: 12082102A2
- Exp 3/8/2022
- 02212201A1
- Exp 5/22/2022.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27